Back to results
US 2024/0189267 A1Published application
Therapeutic agents for neurodegenerative diseases
AssigneeIntrabio Ltd.
InventorMichael STRUPP
Life of this patent
Estimating the term…
Abstract
The present disclosure provides for treating neurodegenerative diseases comprising administering acetyl-leucine or a pharmaceutically acceptable salt thereof.
Claims20
1-29. (canceled)
A method of delaying progression of a neurodegenerative disease or one or more symptoms associated with a neurodegenerative disease in a subject in need thereof comprising:
- administering a therapeutically effective amount of acetyl-leucine or a pharmaceutically acceptable salt thereof to the subject, wherein the neurodegenerative disease is Parkinson's disease, or one or more symptoms associated with Parkinson's disease.
A method of delaying onset of a neurodegenerative disease or one or more symptoms associated with a neurodegenerative disease in a subject in need thereof comprising:
- administering a therapeutically effective amount of acetyl-leucine or a pharmaceutically acceptable salt thereof to the subject, wherein the neurodegenerative disease is Parkinson's disease, or one or more symptoms associated with Parkinson's disease.
Dependencies are inferred from the claim text.